Shares of Nektar Therapeutics (NASDAQ:NKTR) added ~9% in the premarket on Friday after Oppenheimer upgraded the biopharma to ...

In February, in the wake of an international AI Summit in Paris, Anthropic CEO Dario Amodei restated his belief that by 2030 ...

Oppenheimer analyst Jay Olson downgraded Sutro Biopharma (STRO) to Perform from Outperform after the company reported Q4 results and announced ...

(JTA) — Friday is not just “Barbie” release day — moviegoers are also planning to fill theaters across the United States to see Christopher Nolan’s “Oppenheimer” biopic. Many hope it ...

Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) was upgraded by equities research analysts at Oppenheimer from a “market ...

AI, as an immortal intelligence, does not experience death, fear, or existential urgency. This raises profound questions: How ...

Netflix’s CCO Bela Bajaria believes Oppenheimer would have thrived on streaming. But would it really match its box office ...

Goldman Sachs analysts are cautioning that “confidence in the US growth story is moderating” and the U.S. stock market may continue to lag behind other global markets.

Oppenheimer Holdings' profit margin is lacking behind key peers, particularly Morgan Stanley, who is also a key competitor.

In a report released today, Brian Schwartz from Oppenheimer maintained a Hold rating on Sprinklr (CXM – Research Report). The company’s shares ...

Showtime has cast David Dastmalchian ( Oppenheimer) in Dexter: Resurrection in the guest starring role of “Gareth.” ...